FINANCE NOMINATING & CORPORATE  GOVERNANCE SCIENCE & TECHNOLOGY CORPORATE OFFICERS EXECUTIVE COMMITTEE WORLDWIDE CHAIRMEN CONSUMER GROUP MEDICAL DEVICES &  DIAGNOSTICS GROUP PHARMACEUTICALS GROUP COMPANY GROUP  CHAIRMEN The Finance Committee exercises the authority of the  Board during the intervals  between Board meetings. The Finance Committee is  composed of the Chairman of  the Board and the Presiding  Director.  The Nominating & Corporate  Governance Committee,  composed entirely of independent Directors, is  responsible for overseeing  corporate governance matters,  reviewing possible candidates  for Board membership and  recommending nominees for  election. The Committee is  also responsible for overseeing  the process for performance  evaluations of the Board and  its committees. Additionally,  the Committee reviews the  Company’s executive succession plans and executive resources.  William D. Perez,  Chairman James G. Cullen Anne M. Mulcahy Charles Prince PUBLIC POLICY The Public Policy Advisory  Committee reviews the Company’s policies, programs  and practices on public health  issues regarding the environ- ment and the health and safety  of employees. The Committee  also reviews the Company’s governmental affairs and policies and other public policy  issues facing the Company. The Committee advises and  makes recommendations  to the Board on these issues  as appropriate. The Public  Policy Advisory Committee  is composed of independent  28 Mary Sue Coleman, Ph.D. Michael M. E. Johns, M.D.  Susan L. Lindquist, Ph.D. Garry A. Neil, M.D. David Satcher, M.D., Ph.D.,  Chairman The Science & Technology  Advisory Committee, composed  of independent Directors and  the Company’s Vice President,  Science and Technology, helps  the Board with scientific matters  impacting the Company’s business, including monitoring  the strategy and effectiveness  of the Company’s research and  development organization; reviewing the effectiveness  of scientific aspects of the  Company’s product safety  processes; overseeing major  business development activities  related to the acquisition of  new science or technology; and  identifying and understanding  significant new science and technology policy issues and  trends. Leo F. Mullin,  Chairman Ian E. L. Davis Alex Gorsky Clifford E. Holland  Susan L. Lindquist, Ph.D.  Brian D. Perkins David Satcher, M.D., Ph.D.  Ajit S. Shetty, Ph.D. William C. Weldon,  Chairman James G. Cullen  Directors; one of the Company’s Vice Chairmen,  Executive Committee; and the  Vice Presidents for Corporate  Affairs, Government Affairs and  Policy, and Johnson & Johnson  Supply Chain. WILLIAM C. WELDON Chairman, Board of Directors Chief Executive Officer Chairman, Executive Committee DOMINIC J. CARUSO Vice President Finance Chief Financial Officer Executive Committee DOUGLAS K. CHIA Corporate Secretary Assistant General Counsel STEPHEN J. COSGROVE Corporate Controller LAVERNE H. COUNCIL Vice President  Chief Information Officer RUSSELL C. DEYO Vice President General Counsel Executive Committee PETER M. FASOLO Worldwide Vice President Human Resources Executive Committee ALEX GORSKY Vice Chairman  Executive Committee  RAYMOND C. JORDAN Vice President Public Affairs &  Corporate Communication SHERILYN S. MCCOY  Vice Chairman  Executive Committee JOHN A. PAPA Treasurer BRIAN D. PERKINS Vice President Corporate Affairs The Executive Committee of Johnson & Johnson is the  principal management  group responsible for the  operations and allocation of  the resources of the Company.  This Committee oversees and  coordinates the activities of the  Consumer, Pharmaceuticals  and Medical Devices and  Diagnostics business segments.  Each subsidiary within the  business segments is, with  some exceptions, managed by  citizens of the country where it  is located. Jesse J. Wu Michael F. Mahoney Joaquin Duato Paul Stoffels, M. D.  ROBERTO DE O. MARQUES  MICHAEL J. F. DEL PRADO SETH H. Z. FISCHER GARY FISCHETTI JANE GRIFFITHS GUY J. LEBEAU, M.D. KAREN A. LICITRA PATRICK D. MUTCHLER DAVID Y. NORTON MICHEL PAUL JACQUES PEETERS GARY J. PRUDEN MARC E. ROBINSON MICHAEL E. SNEED PERICLES P. STAMATIADES KIM TAYLOR  NICHOLAS J. VALERIANI  JOHNSON & JOHNSON 2010 ANNUAL REPORT